GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Pre-Tax Income

Affymax, (FRA:A5Y) Pre-Tax Income : €1.99 Mil (TTM As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is Affymax, Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Affymax,'s pretax income for the three months ended in Jun. 2014 was €5.31 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2014 was €1.99 Mil. Affymax,'s pretax margin was 17,116.13%.

During the past 13 years, Affymax,'s highest Pretax Margin was 7300.00%. The lowest was -1211.25%. And the median was -99.01%.


Affymax, Pre-Tax Income Historical Data

The historical data trend for Affymax,'s Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Pre-Tax Income Chart

Affymax, Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.47 -10.64 -46.64 -71.20 -12.11

Affymax, Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 -1.27 -1.05 -1.01 5.31

Competitive Comparison of Affymax,'s Pre-Tax Income

For the Biotechnology subindustry, Affymax,'s Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affymax,'s Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax,'s Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Affymax,'s Pre-Tax Income falls into.



Affymax, Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Affymax,'s Pretax Income for the fiscal year that ended in Dec. 2013 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-27.752+16.775+-1.142+0.015+-0.0010000000000012
=-12.11

Affymax,'s Pretax Income for the quarter that ended in Jun. 2014 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.754+6.059+0+0+0.0010000000000003
=5.31

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affymax,  (FRA:A5Y) Pre-Tax Income Explanation

Affymax,'s Pretax Margin for the quarter that ended in Jun. 2014 is calculated as

Pretax Margin=Pretax Income/Revenue
=5.306/0.031
=17,116.13%

During the past 13 years, Affymax,'s highest Pretax Margin was 7300.00%. The lowest was -1211.25%. And the median was -99.01%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affymax, Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Affymax,'s Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Affymax, (FRA:A5Y) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines